Skip to main content
Caplight Logo









PerioTrap Pharmaceuticals GmbH

PerioTrap Pharmaceuticals GmbH

Private
Halle (Saale)Healthcare & Life Scienceshttps://periotrap.com

Last Round

VC Round

Feb 6, 2025

Total Funding Raised

$3.54M

Company Overview

PerioTrap Pharmaceuticals GmbH is a life sciences company that develops an innovative anti-infective drug for the curative treatment of periodontitis, an inflammatory gum disease caused by specific bacteria.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Fashion & Beauty

Business Model

B2B2C

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

pathoblockermicrobiome oral careselective inhibitorperiodontitis treatmentgum disease preventionoral microbiomePorphyromonas gingivalissmall-molecule inhibitorchlorhexidine alternativeprofessional dental geldental biotechveterinary oral care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PerioTrap Pharmaceuticals GmbH Comparables

Compare PerioTrap Pharmaceuticals GmbH with similar companies based on industry and business-model similarity.

PerioTrap Pharmaceuticals GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProEncia Biotechnology
82%
Kaneka Corporation
66%
Bausch Health Companies
64%

PerioTrap Pharmaceuticals GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 6, 2025
SeedOct 21, 2020

Key People

Founding team and executive leadership

Pierre Tangermann

CEO

Executive Team

PerioTrap Pharmaceuticals GmbH Investors

Notable investors and investment history

PerioTrap Pharmaceuticals GmbH investors
InvestorRounds
Bmp VenturesVC Round
Fraunhofer VentureSeed, VC Round
i&i PragueSeed, VC Round
CompanistoVC Round

PerioTrap Pharmaceuticals GmbH Filings

Explore SEC and related filing metadata, where available.

PerioTrap Pharmaceuticals GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PerioTrap Pharmaceuticals GmbH's valuation, stock price, and market status.

Is PerioTrap Pharmaceuticals GmbH a public or private company?

PerioTrap Pharmaceuticals GmbH is a private company.

What is the current stock price of PerioTrap Pharmaceuticals GmbH?

PerioTrap Pharmaceuticals GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is PerioTrap Pharmaceuticals GmbH worth (valuation)?

Valuation information for PerioTrap Pharmaceuticals GmbH is not publicly available.

Can I buy PerioTrap Pharmaceuticals GmbH stock?

PerioTrap Pharmaceuticals GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PerioTrap Pharmaceuticals GmbH's last funding round?

PerioTrap Pharmaceuticals GmbH's most recent funding round was VC Round on February 6, 2025.

Who are the main investors in PerioTrap Pharmaceuticals GmbH?

Key investors in PerioTrap Pharmaceuticals GmbH include Bmp Ventures, Fraunhofer Venture, i&i Prague, Companisto.

Will PerioTrap Pharmaceuticals GmbH IPO soon?

No public IPO plans have been announced for PerioTrap Pharmaceuticals GmbH.

How can I track PerioTrap Pharmaceuticals GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PerioTrap Pharmaceuticals GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHalle (Saale)
Employee Range10
Year Founded2019
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?